Turkey Parvovirus

Overview and Taxonomy of Turkey Parvovirus (TuPV)

Turkey parvovirus (TuPV) occupies a distinctive and increasingly complex position within the family Parvoviridae, a taxon comprising small, non-enveloped, single-stranded DNA viruses that infect a remarkably broad spectrum of vertebrate and invertebrate hosts. The family is subdivided into three subfamilies, Parvovirinae, Densovirinae, and Hamaparvovirinae, with TuPV firmly positioned within the subfamily Parvovirinae [7, 15]. Historically, the taxonomic placement of avian parvoviruses has undergone substantial revision as molecular phylogenetic analyses have supplanted earlier classification schemes based primarily on host species and clinical presentation. The genus Aveparvovirus was formally established by the International Committee on Taxonomy of Viruses (ICTV) to accommodate the parvoviruses infecting birds, with TuPV and chicken parvovirus (ChPV) serving as the prototypical members of this genus [7, 13, 16]. This taxonomic distinction reflects fundamental genomic and structural features that differentiate avian parvoviruses from their mammalian counterparts, including members of the genera Protoparvovirus (such as canine parvovirus type 2, CPV-2) and Bocaparvovirus [1, 7, 10].

Genomic Organization and Structural Features

The TuPV genome is a linear, single-stranded DNA molecule of approximately 5.0–5.5 kilobases in length, encapsidated within a non-enveloped, T=1 icosahedral capsid measuring approximately 25 nm in diameter [4, 7, 10]. The genome architecture follows the canonical parvoviral organization, comprising three major open reading frames (ORFs). The first ORF encodes the non-structural protein NS1 and its smaller variant NS2, which are essential for viral DNA replication, transcriptional regulation, and cytotoxicity [7, 9]. The second ORF encodes a nuclear phosphoprotein (NP) of uncertain but likely regulatory function, while the third ORF encodes the viral capsid proteins VP1 and VP2 [7, 9]. Notably, VP2 constitutes the major capsid protein and is the primary target of host neutralizing antibodies, making it a critical determinant of antigenic diversity and immune evasion [1, 5, 10]. In contrast to mammalian parvoviruses, the VP1-unique region of TuPV and other avian parvoviruses lacks the canonical phospholipase A2 (PLA2) enzymatic motif that is typically required for endosomal escape during cellular entry [7]. This distinctive feature suggests that avian parvoviruses may employ alternative, as-yet-uncharacterized mechanisms for host cell penetration, representing a fundamental divergence in the infection strategy of this viral lineage [7, 16].

Recent high-resolution structural studies have revolutionized our understanding of the TuPV capsid architecture. Cryo-electron microscopy (cryo-EM) reconstructions of the TuPV capsid at 2.35 Å resolution have revealed a surface topology that, while sharing conserved features with other parvoviruses, such as a prominent channel at the fivefold symmetry axis and surface depressions at the twofold axis, exhibits major structural differences at the threefold axes, which display recessed protrusions that are unique among parvoviral capsids [4]. These structural idiosyncrasies have profound implications for receptor binding, antigenicity, and potential vaccine design. Furthermore, the identification of terminal sialic acid as a potential glycan receptor for the related red-crowned crane parvovirus (RCPV) suggests that sialic acid-binding may represent a conserved feature within the genus Aveparvovirus, although direct experimental confirmation for TuPV remains an active area of investigation [4].

Phylogenetic Relationships and Genetic Diversity

Comprehensive phylogenetic analyses of TuPV isolates from diverse geographical regions have revealed a complex and dynamic evolutionary landscape. The earliest molecular characterizations of TuPV were based on partial NS1 gene sequences, which initially suggested a clear division into TuPV-like and ChPV-like clusters [7, 9, 14]. However, as whole-genome sequencing has become more accessible, a more nuanced picture has emerged, characterized by substantial genetic heterogeneity and evidence of inter-species recombination. Zhang and colleagues (2023) conducted a landmark phylogenetic analysis of 32 ChPV and 3 TuPV strains from Guangxi, China, which, when combined with 17 reference strains, resolved six distinct phylogenetic groups [1]. Crucially, three of these groups were identified for the first time, demonstrating that the genetic diversity of avian parvoviruses is far greater than previously appreciated [1]. The whole-genome phylogenetic trees constructed in this study did not show clustering according to geographic origin, indicating that long-distance dissemination of viral strains occurs frequently, likely mediated by international trade in poultry and poultry products [1].

The relationship between TuPV and ChPV is particularly intriguing and taxonomically challenging. Nucleotide sequence alignments between TuPV and ChPV isolates typically reveal 79.8–92.1% identity, with the TuPV strain GX-Tu-PV-1 from Guangxi exhibiting 81.3–99.3% similarity to other TuPVs and 79.8–92.1% similarity to ChPVs [2]. This degree of divergence is consistent with the classification of TuPV and ChPV as distinct but closely related species within the genus Aveparvovirus [1, 2, 7]. However, the detection of naturally occurring recombinant viruses, such as a ChPV isolate that clusters phylogenetically within the TuPV group, provides compelling evidence that recombination between these two species can and does occur in the field [14]. This phenomenon has been confirmed by multiple research groups using sophisticated recombination detection algorithms, including RDP 5.0 and Simplot 3.5.1 [1, 5, 11, 14]. The identification of 15 recombinant events among 35 ChPV/TuPV isolates from Guangxi underscores the frequency with which recombination shapes the genetic diversity of these viruses [1]. Such recombination events may facilitate the emergence of novel variants with altered host range, tissue tropism, or pathogenicity, posing challenges for both diagnostic detection and vaccine development.

The Emergence of Novel Genotypes and Subtypes

The genotyping system for avian parvoviruses has evolved substantially in response to the growing body of sequence data. For ChPV, a novel genotyping system based on p-distance frequency distribution and neighbor-joining phylogenetic analysis of VP2 amino acid sequences has recently been proposed, classifying ChPV into two major genotypes, CKPV-1 (with subtypes CKPV-1a and CKPV-1b) and CKPV-2 (with subtypes CKPV-2a, CKPV-2b, and CKPV-2c) [3]. While a parallel systematic genotyping scheme has not yet been formally established for TuPV, the genetic diversity observed among turkey isolates suggests that a similar multi-genotype classification will be necessary [1, 3, 14]. The Polish TuPV isolates, in particular, have revealed a previously unrecognized and distinct subgroup designated TuPV-LUB, which exhibited as little as 50.6–64.5% nucleotide sequence identity to prototype chicken and turkey parvovirus strains [14]. This remarkable degree of divergence suggests that the TuPV-LUB lineage may represent a novel genotype or even a distinct species within the genus Aveparvovirus [14].

The detection of chaphamaparvoviruses (genus Chaphamaparvovirus, subfamily Hamaparvovirinae) in turkeys adds another layer of complexity to the taxonomy and ecology of parvoviruses affecting this host species. Aslan and colleagues (2025) reported the first detection of Chaphamaparvovirus galliform (GaChpV) in turkey flocks in Türkiye, with a prevalence of 6.6% (2/30 flocks) [6]. The nucleotide sequences of the capsid genes from these turkey-derived GaChpV strains were 99–100% identical to those from broiler chickens, suggesting cross-species transmission between chickens and turkeys [6]. Phylogenetic analyses revealed that the Turkish GaChpV strains clustered with GaChpV-2 strains from Europe, China, and Brazil, with complete genome sequencing of a broiler strain yielding a genome of 4,229 nucleotides and sequence identity ranging from 78.93% to 98.82% compared to other GaChpV strains [6]. The co-circulation of both aveparvoviruses (TuPV) and chaphamaparvoviruses (GaChpV) in turkey populations highlights the need for careful diagnostic differentiation and suggests that the parvoviral burden in turkeys involves multiple distinct viral lineages with potentially different biological properties.

Epidemiological Prevalence and Host Range

The prevalence of TuPV in commercial turkey flocks varies considerably across geographical regions and production systems. Large-scale surveillance studies have demonstrated that TuPV is widely distributed in turkey populations worldwide. In Guangxi, China, TuPV was detected in 83.33% (70/84) of turkey samples tested between 2014 and 2019, a finding that underscores the high endemicity of this virus in Asian poultry production systems [8, 12]. In Europe, the prevalence appears somewhat lower but remains substantial: Domańska-Blicharz and colleagues (2012) reported TuPV prevalence of 29.4% in Polish turkey flocks [14], while a subsequent cross-sectional survey of 207 Polish turkey flocks between 2008 and 2011 revealed an overall parvovirus prevalence of 27.5% (95% CI: 21.6–34.2) [9]. In Minnesota, United States, parvovirus was detected in 51.25% (41/80) of fecal pools from flocks affected by light turkey syndrome (LTS) and in 57.14% (20/35) of pools from non-LTS flocks, confirming that TuPV circulates extensively even in flocks without overt clinical signs [11]. A systematic review and meta-analysis of enteric viruses in turkeys confirmed the global distribution of TuPV, with prevalence estimates varying widely depending on diagnostic methods, sampling strategies, and flock health status [13].

The age distribution of TuPV infection is a critical epidemiological parameter. Young turkeys aged 1–4 weeks exhibit the highest prevalence of parvovirus infection, with 82.1% (95% CI: 71.7–89.8) of flocks in this age group testing positive for at least one enteric virus [9]. This age-dependent susceptibility is consistent with the waning of maternally derived antibodies and the immaturity of the adaptive immune system in young poults [9, 11, 13]. The detection of TuPV in meconium samples and in day-old poults raises the possibility of vertical transmission, although experimental confirmation of transovarial transmission remains lacking [11, 17, 18].

Pathological Associations and Clinical Significance

TuPV was first identified in association with enteric disease syndromes in turkeys, particularly poultry enteritis and mortality syndrome (PEMS) and runting-stunting syndrome (RSS) [7, 8, 12, 13]. These syndromes are characterized by diarrhea, depression, poor feed conversion, stunted growth, and increased mortality, resulting in substantial economic losses to the turkey industry worldwide [7, 9, 13]. However, the etiological role of TuPV in these syndromes remains incompletely understood, as the virus is frequently detected in both diseased and healthy birds [9, 11, 13]. Statistical analyses of Polish turkey flocks indicated that parvovirus infection alone was not significantly associated with clinical disease, but co-infection with multiple enteric viruses, particularly astrovirus and rotavirus, was more strongly correlated with enteritis [9]. This suggests that TuPV may act as a component of a polymicrobial enteric disease complex rather than as a primary pathogen in isolation [9, 13]. In the Minnesota studies, TuPV was detected at comparable rates in LTS-affected and non-LTS flocks, further complicating the assessment of its pathogenic role [11]. Nevertheless, the detection of a divergent TuPV strain showing only 90% nucleotide identity to prototype strains and clustering with chicken-like parvoviruses in LTS flocks suggests that particular viral variants may possess enhanced virulence or altered tissue tropism [11].

Implications for Diagnostic and Control Strategies

The taxonomic and genetic diversity of TuPV has direct implications for diagnostic assay design and vaccine development. The high degree of sequence variability, particularly in the NS1 and VP2 genes, means that PCR-based diagnostic assays must be carefully designed to ensure detection of all circulating variants [1, 7, 19]. Comparative studies of PCR primer sets for ChPV detection have demonstrated that assay sensitivity can vary dramatically, with positivity rates ranging from 7.9% to 44.6% depending on the primer set used [19]. This variability underscores the need for ongoing evaluation and optimization of molecular diagnostic tools as new genetic variants emerge [19, 20]. The World Organisation for Animal Health (WOAH) has recognized the economic importance of enteric diseases in poultry, and the development of standardized diagnostic protocols for TuPV is a priority for international surveillance efforts. Currently, no commercial vaccine is available for TuPV, and control relies on biosecurity measures, including all-in-all-out management, disinfection of poultry houses, and prevention of fecal-oral transmission [4, 7, 13]. The recent structural characterization of the TuPV capsid provides a foundation for rational vaccine design, as the identification of conserved antigenic epitopes and the mapping of B-cell and T-cell epitopes could guide the development of recombinant subunit or virus-like particle vaccines [4, 5]. The Food and Agriculture Organization (FAO) has highlighted the need for improved disease control strategies in poultry production systems to enhance global food security, and the development of effective TuPV vaccines would represent a significant contribution to this goal.

Evolutionary Dynamics and Future Directions

The evolutionary trajectory of TuPV is shaped by multiple forces, including nucleotide substitution, genetic recombination, and host-driven selection pressure. Selective pressure analyses of avian parvoviruses indicate that most coding genes in Aveparvovirus galliform1 are evolving under diversifying (negative) selection, meaning that amino acid changes are generally deleterious and are purged from the population [5]. However, specific regions of the VP1, VP2, and NS1 proteins exhibit hypervariability, particularly within predicted B-cell epitope regions, suggesting that immune pressure from the host drives adaptive evolution at these sites [3, 5]. The identification of 22 amino acid substitutions within predicted B-cell epitope regions of ChPV capsid proteins [3] and the demonstration of host-specific variability in antigenic peptides between ChPV and TuPV [5] highlight the ongoing arms race between virus and host immune system. The potential for TuPV to undergo further antigenic drift and shift, through both mutation and recombination, necessitates continued molecular surveillance to inform vaccine strain selection and to anticipate the emergence of variants with altered pathogenicity or host range. The recent detection of TuPV-related sequences in wild birds, including pigeons [16] and rats [15], raises the possibility that wildlife reservoirs may contribute to the maintenance and dissemination of genetic diversity in avian parvoviruses, underscoring the need for a One Health approach to the epidemiology and control of these economically important pathogens.

Molecular Characterization and Genomic Diversity of TuPV

The molecular architecture of turkey parvovirus (TuPV) is emblematic of the genus Aveparvovirus within the subfamily Parvovirinae of the family Parvoviridae [7]. TuPV possesses a non-enveloped, icosahedral capsid of approximately 25 nm in diameter, encapsidating a linear, single-stranded DNA genome of roughly 5.0 to 5.2 kilobases [4, 7]. The genome is organized into three principal open reading frames (ORFs). The first ORF encodes the non-structural protein 1 (NS1), a multifunctional protein essential for viral DNA replication, helicase activity, and transcriptional regulation [7]. A second, smaller ORF encodes the nuclear phosphoprotein (NP), whose precise function in avian parvoviruses remains less defined but is suspected to play roles in capsid assembly and nuclear transport. The third and largest ORF encodes the viral capsid proteins VP1 and VP2, which are generated through alternative splicing of a common precursor transcript [7]. VP2 constitutes the primary structural component of the capsid and is the major target of the host humoral immune response [5, 7]. A distinctive feature of the TuPV (and other aveparvoviruses) is that the VP1-unique region (VP1u) lacks the phospholipase A2 (PLA2) enzymatic motif that is characteristically conserved among mammalian parvoviruses, suggesting a unique, yet-to-be-elucidated mechanism for endosomal escape during cellular entry [7].

Phylogenetic analyses have revealed a complex and expanding landscape of genetic diversity. Early studies classified TuPV strains into a distinct cluster, clearly separable from chicken parvovirus (ChPV) and waterfowl parvoviruses [7]. However, more comprehensive genomic surveys, particularly those leveraging complete genome sequencing, have demonstrated that TuPV isolates form multiple distinct clades. Zhang et al. [1], in a landmark study of 35 avian parvovirus strains from Guangxi, China (including three TuPVs), performed phylogenetic reconstructions using the full genome, NS1, NP, and VP2 gene sequences. Their analysis resolved six distinct genogroups within the ChPV/TuPV complex, three of which were described for the first time, significantly expanding our understanding of the genetic breadth of these viruses [1]. Crucially, Guangxi TuPV strains did not cluster strictly by geographic origin, indicating that viral migration and global dissemination have led to a complex intermingling of lineages across continents [1].

This phylogeographic complexity is further underscored by studies from Europe. Domanska-Blicharz et al. [14] conducted a large-scale molecular survey of Polish turkey and chicken flocks between 2008 and 2011. Their phylogenetic analysis of partial NS1 gene sequences revealed not only the expected TuPV-like and ChPV-like clusters, but also a distinct, previously unrecognized subgroup designated TuPV-LUB, which contained three Polish turkey isolates. These TuPV-LUB isolates displayed remarkably low nucleotide sequence identity (50.6–64.5%) to prototype chicken and turkey parvovirus strains, suggesting the circulation of highly divergent lineages in European turkey populations [14]. Loor-Giler et al. [13] further reinforced the theme of extensive regional and genetic variability in enteric viruses of turkeys, emphasizing the necessity of continuous molecular surveillance to capture the full spectrum of circulating strains.

The complete genome sequencing of the TuPV strain GX-Tu-PV-1, isolated from a Guangxi turkey, provided the first high-resolution reference for Chinese TuPVs. This strain exhibited nucleotide sequence similarities of 81.3% to 99.3% with other TuPVs and 79.8% to 92.1% with ChPV strains, confirming the inter-species variability and the existence of a genetic continuum between chicken and turkey parvoviruses [2]. Subsequent large-scale surveillance in Guangxi (2014–2019) detected TuPV in an astonishing 83.33% of turkey flocks tested, with the highest prevalence in open-house systems and during the spring season, underscoring the importance of environmental and management factors in transmission dynamics [8, 12].

Recombination as a Driver of Genomic Diversity

Recombination is a potent evolutionary force shaping the diversity of TuPV. The single-stranded DNA genome of parvoviruses is susceptible to homologous recombination during co-infection of a host cell with divergent strains. Zhang et al. [1] performed an exhaustive recombination analysis using RDP 5.0 on 35 ChPV/TuPV field isolates from Guangxi. They identified a staggering 15 putative recombinant strains, with multiple recombination events subsequently confirmed by Simplot 3.5.1 analysis [1]. These findings indicate that recombination is not a rare event but a common mechanism generating genetic novelty within avian parvovirus populations.

Evidence for recombination has also emerged from European and North American studies. Domanska-Blicharz et al. [14] reported a ChPV isolate that phylogenetically clustered within the TuPV group, a finding that was strongly suggestive of a recombination event between chicken and turkey parvoviruses. Similarly, Sharafeldin et al. [11] identified a divergent TuPV strain in Minnesota turkeys (from both light turkey syndrome [LTS] and non-LTS flocks) whose partial NS1 sequence shared only 90% nucleotide identity with other TuPVs and instead clustered with "chicken-like" parvoviruses, providing further evidence for a recombinant origin [11]. This suggests that the interspecies barrier between chickens and turkeys is not absolute and that co-infection with ChPV and TuPV can generate hybrid viruses with potentially altered host range, pathogenicity, or antigenic properties. The implications for disease control are profound, as recombination can rapidly generate escape mutants that circumvent vaccine-induced immunity or diagnostic detection.

Structural Biology and Capsid Architecture

A landmark advancement in the molecular characterization of TuPV came with the determination of its high-resolution capsid structure by cryo-electron microscopy (cryo-EM). Hsi et al. [4] resolved the TuPV capsid to an impressive 2.35 Å resolution, revealing a T=1 icosahedral arrangement that is a hallmark of the Parvoviridae family. The structure exhibited conserved parvoviral features, including a channel at the five-fold symmetry axis (likely involved in genome packaging and externalization) and surface depressions at the two-fold axes. However, a distinct structural divergence was identified at the three-fold axes, where both TuPV and the related red-crowned crane parvovirus (RCPV) displayed recessed protrusions, differing significantly from the prominent spike-like structures seen in mammalian parvoviruses like canine parvovirus type 2 (CPV-2) [4]. This structural variation likely influences receptor binding and host tropism. A comparative analysis of capsid protein models further predicted high conservancy in the VP2 region across different TuPV and ChPV strains, though host-specific variability in predicted B-cell and T-cell epitopes was noted, suggesting adaptation to host immune pressures [5].

Selective Pressure and Evolutionary Dynamics

The evolution of TuPV is not solely driven by recombination; selective pressure also plays a critical role. Chacón et al. [5] performed selective pressure analysis on Aveparvovirus galliform1 genomes (the species encompassing both ChPV and TuPV). Their analysis indicated that most coding genes are evolving under diversifying (negative) selection, meaning that non-synonymous mutations are generally purged to maintain functional protein integrity. However, specific codons within the VP2 capsid protein were found to be under positive (adaptive) selection, particularly those located within predicted B-cell epitopes [5]. This signature of adaptive evolution suggests that host antibody-mediated immunity is a powerful driver of antigenic variation in TuPV, analogous to the immune-driven evolution seen in CPV-2 [21-23]. The identification of hypervariable regions in the VP1 protein (residues 250–267 and 611–667) and capsid proteins (with 22 amino acid substitutions in predicted B-cell epitopes) in chicken parvoviruses suggests that similar, parallel evolutionary forces are operating in TuPV [3].

The detection of TuPV (and its genetic material) in environmental samples, including poultry house litter, drinking water, and swabs, is a critical epidemiological finding [8, 12]. The virus's DNA is sufficiently stable in the environment that it can be used as a surrogate marker for fecal contamination in microbial source tracking studies [24]. This environmental persistence, combined with the high prevalence observed in young birds (1–4 weeks old) [9], underscores the importance of rigorous biosecurity protocols. The lack of a commercial vaccine for TuPV [4, 7] makes molecular characterization and surveillance the primary tools for understanding and mitigating its impact on global turkey production, particularly in the context of enteric disease syndromes like poult enteritis complex (PEC) and runting-stunting syndrome (RSS) [5, 7, 13, 18].

Molecular Pathogenesis and Host-Virus Interactions

Structural Basis of Cellular Tropism and Viral Entry

The molecular pathogenesis of Turkey Parvovirus (TuPV) is fundamentally dictated by the architectural features of its icosahedral capsid, a T=1 structure approximately 25 nm in diameter that packages a linear single-stranded DNA genome [4]. High-resolution cryo-electron microscopy of TuPV capsids at 2.35 Å resolution has revealed critical structural determinants governing host cell recognition and entry [4]. Unlike many other parvoviruses, the TuPV capsid exhibits recessed protrusions at the three-fold symmetry axes, a distinctive feature that differentiates it from the prototypical surface topologies observed in dependoparvoviruses and protoparvoviruses [4]. This recessed configuration at the three-fold axes likely modulates interactions with host cell surface receptors and may influence tissue tropism within the avian enteric tract.

The capsid surface at the two-fold symmetry axis presents prominent depressions, while the five-fold axes contain channels that are conserved across the Parvoviridae family [4]. These five-fold channels are hypothesized to serve as portals for genome packaging and externalization during infection, a mechanism well-characterized in mammalian parvoviruses. Critically, structural comparisons with other aveparvoviruses, including red-crowned crane parvovirus, demonstrate that terminal sialic acid residues function as potential glycan receptors for TuPV, analogous to the sialic acid binding properties observed in many protoparvoviruses [4]. This suggests that TuPV entry into host cells is mediated through attachment to sialylated glycoconjugates expressed on the apical surface of intestinal epithelial cells, providing a molecular explanation for the virus's pronounced tropism for the gastrointestinal tract.

The absence of a phospholipase A2 (PLA2) enzymatic motif within the VP1-unique region of TuPV represents a significant deviation from the entry mechanisms employed by most other parvoviruses [7]. In mammalian parvoviruses, the PLA2 domain is essential for endosomal escape and productive infection. The lack of this motif in TuPV implies that the virus has evolved alternative, as-yet-uncharacterized mechanisms for membrane penetration and cytosolic delivery of its genome. This unique feature may influence the kinetics of viral uncoating, the efficiency of nuclear import of viral DNA, and ultimately, the pathogenic potential within turkey intestinal tissues.

Genomic Organization and Replication Strategy

The TuPV genome, approximately 5.0-5.2 kb in length, is organized into three primary open reading frames (ORFs) [7]. The first two ORFs encode the non-structural protein 1 (NS1) and a nuclear phosphoprotein (NP), while the third ORF directs the synthesis of the viral capsid proteins VP1 and VP2 through alternative splicing mechanisms [7]. NS1 is the master regulator of viral replication, possessing both helicase and nicking-joining activities essential for rolling-circle replication of the single-stranded DNA genome. The NS1 protein of TuPV exhibits the characteristic SF3 helicase domain containing conserved Walker A and Walker B motifs, which are necessary for ATP hydrolysis and DNA unwinding during replication [7].

The NP protein, a distinctive feature of aveparvoviruses, localizes to the nucleus of infected cells and is believed to play roles in viral DNA replication and transcriptional regulation, though its precise functions in TuPV pathogenesis remain to be fully elucidated [7]. The VP2 protein, which constitutes the major capsid component, is translated from a spliced mRNA that also encodes VP1 as a larger, minor capsid protein via an alternative start codon. The VP1-unique region, while lacking PLA2 activity, may still contain nuclear localization signals or other functional domains critical for capsid assembly and genome encapsidation.

Replication of TuPV is strictly dependent on host cellular DNA polymerase and occurs within the S phase of the cell cycle, as the virus does not encode its own DNA polymerase [7]. This S-phase dependence explains the pronounced tropism of parvoviruses for rapidly dividing cells, such as the proliferating crypt epithelial cells of the intestinal mucosa. In young poults, the high mitotic activity of enterocytes lining the intestinal crypts provides an optimal environment for efficient TuPV replication, leading to extensive destruction of the epithelial barrier and the clinical manifestations of enteric disease.

Host-Virus Interactions at the Cellular Level

Upon entry into susceptible enterocytes, TuPV initiates a cascade of cellular responses that culminate in cytopathic effect and tissue damage. The interaction between viral capsid proteins and host cell receptors triggers signal transduction pathways that modulate the intracellular environment to favor viral replication. The NS1 protein, in addition to its replicative functions, interacts with multiple host cell factors to induce cell cycle arrest in S phase, thereby creating a cellular milieu permissive for viral DNA replication [7]. NS1-mediated dysregulation of the cell cycle involves interactions with cyclin-dependent kinases and tumor suppressor proteins, leading to the accumulation of infected cells in S phase and subsequent apoptotic cell death.

The capsid proteins VP1 and VP2 are the primary targets of the host humoral immune response. Recombinant VP2 protein has been successfully employed as an antigen in enzyme-linked immunosorbent assays for the detection of TuPV-specific antibodies, demonstrating that VP2 contains immunodominant epitopes capable of eliciting strong B-cell responses [7]. Epitope mapping studies have predicted multiple B-cell linear epitopes within the VP2 protein, and sequence comparisons between TuPV and chicken parvovirus (ChPV) reveal that several antigenic peptides are co-localized, suggesting cross-reactive potential [5]. However, host-specific variability in these epitopes has been observed, driven by adaptive selection pressures imposed by the host immune system [5]. This antigenic variation poses challenges for the development of broadly protective vaccines and may contribute to the emergence of immune escape variants.

T-cell epitopes within the TuPV capsid have also been identified, with in silico predictions indicating the presence of conserved peptide sequences that could be recognized by turkey major histocompatibility complex (MHC) molecules [5]. These T-cell epitopes, particularly those presented by MHC class I molecules, are critical for the activation of cytotoxic T lymphocytes that eliminate virus-infected cells. The co-localization of T-cell epitopes from TuPV and ChPV suggests that a degree of cross-protective cellular immunity may exist between these two closely related aveparvoviruses [5].

Immunopathogenesis and the Role of Co-infections

The pathogenesis of TuPV infection is intrinsically linked to the host immune response and the complex microbial ecology of the avian enteric tract. TuPV is frequently detected in association with other enteric viruses, including astroviruses, rotaviruses, reoviruses, coronaviruses, and chaphamaparvoviruses, creating a multifactorial disease complex that exacerbates clinical severity [9, 13]. Epidemiological surveillance in commercial turkey flocks has demonstrated that co-infections with two or three enteric viruses occur in 39.4% and 6.6% of flocks, respectively, with parvovirus infection present in 27.5% of cases [9]. The highest prevalence of viral enteric infections, including TuPV, is observed in young turkeys aged 1-4 weeks, coinciding with the period of greatest susceptibility to enteric disease syndromes [9].

The interaction between TuPV and the host immune system is characterized by a delicate balance between viral clearance and immunopathology. In healthy birds, the innate immune response, mediated by type I interferons and natural killer cells, provides an initial line of defense that can limit viral replication. However, TuPV has evolved strategies to subvert innate immune responses, likely through NS1-mediated inhibition of interferon signaling pathways, as observed in other parvoviruses. The adaptive immune response, involving both humoral and cellular components, is essential for complete viral clearance. Seroconversion and the production of neutralizing antibodies directed against VP2 are correlated with resolution of infection and protection against reinfection [7].

The detection of TuPV in both diarrheic and apparently healthy birds complicates the understanding of its pathogenic role [9, 11]. Studies of turkey flocks affected by light turkey syndrome (LTS) and poult enteritis syndrome (PES) have detected TuPV in 51.25% of LTS flocks and 57.14% of non-LTS flocks, indicating that TuPV is widespread but not solely responsible for disease [11]. This suggests that TuPV may act as a predisposing factor or a synergistic co-pathogen, with full disease expression requiring additional stressors such as concurrent viral infections, bacterial overgrowth, nutritional imbalances, or environmental stress. The ability of TuPV to persist in the gut of apparently healthy birds raises questions about its role as a commensal or opportunistic pathogen, with disease manifestation dependent on host susceptibility and the presence of co-factors.

Genetic Diversity, Recombination, and Antigenic Variation

The molecular pathogenesis of TuPV is further complicated by the high degree of genetic diversity and the frequent occurrence of recombination events. Whole-genome characterization of TuPV strains from Guangxi, China, has revealed nucleotide sequence similarities ranging from 85.2% to 99.9% among field strains, with amino acid identities between 87.8% and 100% [1]. Phylogenetic analyses have classified avian parvoviruses into six distinct groups, with the identification of three novel groups unique to Guangxi, demonstrating that TuPV exists as a diverse population of genetically related but antigenically distinct variants [1].

Recombination is a major driving force of TuPV evolution, with 15 recombination events detected among 35 ChPV/TuPV isolates from Guangxi using RDP 5.0 and confirmed by Simplot analysis [1]. Evidence of inter-species recombination between chicken and turkey parvoviruses has been documented, with a ChPV isolate clustering within the TuPV group, strongly suggesting a recombination event between these two avian parvoviruses [14]. Furthermore, a divergent TuPV strain identified in Minnesota turkeys exhibiting only 90% nucleotide identity to prototype strains and clustering with chicken-like parvoviruses indicates the circulation of recombinant strains with altered pathogenic potential [11]. These recombination events generate novel viral variants with unpredictable biological properties, including expanded host range, altered tissue tropism, increased virulence, and the capacity to evade pre-existing immunity.

The VP2 gene, which encodes the major capsid protein and primary antigenic target, is a hotspot for genetic variation. Analysis of the VP1/VP2 coding sequence has identified hypervariable regions, particularly at residues 250-267 and 611-667, which correspond to surface-exposed loops of the capsid that are likely involved in receptor binding and antibody recognition [3]. Amino acid substitutions within predicted B-cell epitope regions have been documented, with 22 substitutions identified in circulating strains [3]. Under selective pressure from the host immune system, TuPV populations undergo diversifying (negative) selection, with most coding genes evolving under purifying selection to preserve essential functions while simultaneously adapting to host immune responses [5].

The emergence of novel genotypes and subtypes further illustrates the evolutionary dynamism of avian parvoviruses. A novel genotyping system for chicken parvovirus, based on p-distance frequency distribution and phylogenetic analysis of VP2 sequences, has classified ChPV into two major genotypes (CKPV-1 and CKPV-2) with multiple subtypes [3]. While TuPV strains have not been subjected to a similar systematic classification, the existence of distinct phylogenetic clusters, including a novel third subgroup (TuPV-LUB) comprising Polish turkey isolates with only 50.6-64.5% nucleotide identity to prototype strains, underscores the profound genetic diversity within TuPV and the potential for the emergence of antigenically novel variants [14].

Cellular Tropism and Systemic Dissemination

TuPV exhibits a pronounced tropism for the gastrointestinal tract, with viral replication primarily occurring in the epithelial cells lining the intestinal crypts and villi. Experimental infections have demonstrated that TuPV can be detected in the intestinal contents and fecal material of infected poults, with viral shedding occurring as early as 3-5 days post-infection [7]. The destruction of intestinal epithelial cells leads to villous atrophy, crypt hyperplasia, and disruption of the mucosal barrier, resulting in malabsorption, diarrhea, and dehydration, the cardinal clinical features of enteric disease syndrome.

The ability of TuPV to disseminate beyond the gastrointestinal tract and establish systemic infection remains incompletely characterized. In other avian parvoviruses, such as goose parvovirus (GPV), systemic dissemination with viral detection in liver, spleen, and heart tissues is well-documented, and this may also occur in TuPV infection, particularly in young, immunologically naïve poults [25, 26]. The detection of TuPV DNA in environmental samples collected from poultry houses, including litter, drinking water, and swabs, confirms that infected birds shed virus into their surroundings and that the contaminated environment serves as a major reservoir for horizontal transmission [8, 12].

The fecal-oral route is the primary mode of TuPV transmission, with ingestion of contaminated feed, water, or litter leading to infection of susceptible birds. The high prevalence of TuPV in open-house flocks compared to closed-house systems underscores the importance of environmental contamination in viral spread [8, 12]. Seasonal variation in TuPV prevalence has been observed, with higher detection rates during spring months, possibly reflecting temperature and humidity conditions that favor viral survival in the environment [8, 12]. The ability of TuPV to persist in the environment, coupled with its resistance to many common disinfectants, contributes to its widespread distribution and the difficulty of eradication from infected poultry operations.

Interaction with the Avian Immune System and Immunomodulation

TuPV has evolved sophisticated mechanisms to modulate the host immune response, facilitating persistent infection and enhancing transmission. The NS1 protein, in addition to its replicative functions, can act as a transactivator of host gene expression, potentially influencing the expression of cytokines, chemokines, and other immune mediators. Parvoviral NS1 proteins from other species have been shown to induce DNA damage responses, activate p53-dependent apoptosis, and modulate NF-κB signaling, and it is likely that TuPV NS1 exerts similar immunomodulatory effects.

The humoral immune response against TuPV is directed primarily against the VP2 capsid protein, with neutralizing antibodies targeting conformational epitopes on the capsid surface. The detection of TuPV-specific antibodies in serum samples from infected birds confirms that natural infection elicits a robust antibody response, although the longevity of protective immunity and the degree of cross-protection between different TuPV strains remain poorly defined [7]. Maternal antibodies derived from immune hens can provide passive protection to poults during the first weeks of life, and waning maternal immunity likely contributes to the age-related susceptibility pattern observed in young birds.

The absence of a licensed commercial vaccine for TuPV represents a critical gap in the control of this pathogen [7]. The development of effective vaccines is hampered by the genetic diversity of circulating strains, the lack of standardized challenge models, and the limited understanding of correlates of protective immunity. Recombinant VP2 protein expressed in heterologous systems has shown promise as a subunit vaccine antigen, eliciting virus-neutralizing antibodies and protecting against challenge in experimental settings [7]. However, the emergence of antigenic variants through recombination and mutation necessitates continuous monitoring of circulating strains to ensure vaccine efficacy.

The detection of TuPV in both clinically affected and healthy birds suggests that the virus can establish persistent or latent infections in some hosts, with viral shedding occurring intermittently and contributing to the maintenance of infection within flocks [9, 11]. The mechanisms underlying viral persistence may involve immune evasion strategies such as modulation of MHC expression, inhibition of apoptosis in infected cells, or establishment of a non-cytopathic replicative state that avoids immune recognition.

Interspecies Transmission and Host Range

TuPV is primarily a pathogen of turkeys (Meleagris gallopavo), but molecular evidence indicates that TuPV-related viruses can infect other avian species, including chickens, and that interspecies transmission events may occur more frequently than previously appreciated [1, 2]. The close phylogenetic relationship between TuPV and ChPV, with nucleotide identities ranging from 79.8% to 92.1%, supports the hypothesis that these viruses share a common ancestor and may have undergone host-switching events during their evolutionary history [2]. The detection of TuPV in chickens and ChPV in turkeys, along with the identification of recombinant strains containing genetic elements from both viruses, provides compelling evidence for ongoing interspecies transmission and genetic exchange [1, 14].

The host range of TuPV is determined by the interaction between the viral capsid and cellular receptors, with species-specific differences in receptor expression and structure acting as barriers to cross-species infection. The identification of s

Epidemiology and Global Distribution of TuPV

Turkey parvovirus (TuPV), a member of the genus Aveparvovirus within the subfamily Parvovirinae of the family Parvoviridae, represents a significant etiological agent implicated in the enteric disease complex of commercial turkeys (Meleagris gallopavo) worldwide [7, 13]. Since its initial identification in the early 1980s, TuPV has been recognized as a ubiquitous pathogen, with its distribution now documented across multiple continents, including North America, Europe, and Asia [7, 9, 11]. The epidemiological landscape of TuPV is characterized by high prevalence rates, complex patterns of co-infection with other enteric viruses, substantial genetic diversity driven by recombination and mutation, and a poorly understood but potentially significant role in syndromes such as Poult Enteritis Complex (PEC) and Light Turkey Syndrome (LTS) [8, 9, 11]. Understanding the global distribution and epidemiological drivers of TuPV is paramount for developing effective biosecurity protocols, diagnostic strategies, and, ultimately, intervention measures for an industry where no commercial vaccines currently exist [4, 7].

Global Prevalence and Geographic Distribution

The prevalence of TuPV varies considerably by geographic region, sampling strategy, diagnostic methodology, and the age and health status of the birds sampled. Large-scale epidemiological surveillance has been most comprehensively conducted in China, particularly in the Guangxi Province, where a landmark study by Zhang et al. (2020) assessed parvovirus prevalence in commercial chicken and turkey farms between 2014 and 2019 [8, 12]. This investigation, employing conserved PCR assays targeting the NS1 gene, revealed that TuPV was detected in an astonishing 83.33% (70/84) of turkey flocks sampled [8, 12]. This figure is notably higher than the overall parvovirus prevalence of 51.73% (1,795/3,470) observed across all poultry (chickens and turkeys) in the same study, underscoring the particular susceptibility or exposure of turkeys to this pathogen in that region [8]. The Guangxi data also highlighted critical environmental and management risk factors; environmental samples from poultry houses showed a 47.05% positivity rate, with open-house flocks exhibiting significantly higher prevalence rates than closed-house systems [8, 12]. Specifically, litter from open houses had a positivity rate of 62.86%, and drinking water from these facilities showed 50.00% positivity, compared to 53.57% and 15.69% for litter and water in closed houses, respectively [8]. Furthermore, a pronounced seasonal pattern was observed, with samples collected during the spring months being more frequently positive for ChPV/TuPV than those from other seasons, a finding that may correlate with temperature, humidity, and the stress of early brooding periods [8, 12].

In Europe, comprehensive surveys have provided a contrasting but equally important picture. A cross-sectional study of Polish turkey flocks conducted between 2008 and 2011 by Domańska-Blicharz et al. (2017) examined 207 flocks and found an overall parvovirus prevalence of 27.5% (95% CI: 21.6-34.2) [9]. This study is particularly valuable for its statistical rigor and its analysis of co-infections. Among the 137 flocks (66.2%) positive for any enteric virus, parvovirus was the second most prevalent, following astrovirus (44.9%) [9]. Critically, the study demonstrated that young turkeys aged 1-4 weeks had the highest prevalence of any viral infection (82.1%), and that co-infection with multiple viruses was significantly associated with clinical disease [9]. An earlier Polish study by the same group (Domańska-Blicharz et al., 2012) specifically targeting TuPV and chicken parvovirus (ChPV) found a TuPV prevalence of 29.4% in 197 turkey flocks, confirming the endemic nature of the virus in Central Europe [14]. This study also made the seminal discovery of a novel, highly divergent TuPV subgroup (TuPV-LUB) in three Polish isolates, which shared as little as 50.6-64.5% nucleotide sequence identity with prototype strains, suggesting the existence of far greater genetic diversity than previously appreciated [14].

In North America, the prevalence of TuPV has been investigated in the context of economically devastating syndromes. Sharafeldin et al. (2017) tested fecal pools from Minnesota turkeys, a major turkey-producing state in the USA. They found that 51.25% (41/80) of samples from flocks affected by Light Turkey Syndrome (LTS) were positive for parvovirus, compared to 57.14% (20/35) from non-LTS flocks, indicating that TuPV is highly prevalent regardless of clinical status [11]. However, the study also identified a divergent TuPV strain in LTS flocks that showed only 90% nucleotide identity to other TuPVs and clustered with chicken-like parvoviruses, suggesting the circulation of potential recombinant strains [11]. The prevalence in diagnostic submissions to the Minnesota Veterinary Diagnostic Laboratory was lower (4.3%, 5/116), likely reflecting a bias towards samples from clinically severe cases [11]. These data collectively indicate that TuPV is a globally distributed pathogen, with prevalence rates ranging from approximately 27% in European surveillance studies to over 83% in high-density production areas of China, and that its detection is heavily influenced by the health status of the flock and the sensitivity of the diagnostic tools employed [8, 9, 11, 14].

Molecular Epidemiology and Genetic Diversity

The molecular epidemiology of TuPV is dominated by a high degree of genetic heterogeneity, driven by both point mutations and, more significantly, by recombination events. The seminal work by Zhang et al. (2023) in Guangxi, China, provided the most exhaustive analysis of TuPV and ChPV genetic diversity to date [1]. By sequencing the whole genomes of 35 field strains (including 3 TuPV strains), they demonstrated that nucleotide sequence similarity between Guangxi isolates and global reference strains ranged from 85.2% to 99.9% [1]. Phylogenetic analysis based on full genomes and individual genes (NS1, NP, VP1) revealed a complex structure with six distinct groups, three of which were identified as novel groups for the first time [1]. Crucially, the Guangxi strains did not cluster according to their geographic origin, indicating extensive and ongoing viral traffic and a lack of geographical segregation [1]. This study also employed rigorous recombination analysis using RDP 5.0 and Simplot 3.5.1, identifying 15 recombinant strains among the 35 isolates [1]. This high frequency of recombination (42.8%) underscores the critical role of this mechanism in generating novel genetic variants, potentially with altered antigenicity, host range, or pathogenicity.

The phenomenon of recombination is not limited to China. The Polish study by Domańska-Blicharz et al. (2012) provided strong genetic evidence for a recombination event between chicken and turkey parvoviruses, as a ChPV isolate was found to cluster within the TuPV group [14]. This interspecies recombination has profound implications for the emergence of novel strains capable of crossing species barriers. Further evidence of genetic complexity comes from the structural biology of the virus itself. The recent high-resolution cryo-electron microscopy structures of the TuPV capsid (2.35 Å) by Hsi et al. (2025) revealed that, while TuPV shares conserved parvovirus features like a channel at the five-fold symmetry axis, it displays major structural differences at the three-fold axes, with recessed protrusions [4]. This unique surface topology likely dictates receptor binding, host range, and antigenicity, and provides a structural basis for the genetic variability observed in the VP2 capsid protein [4, 5]. The absence of a phospholipase A2 (PLA2) motif in the VP1-unique region of avian parvoviruses, a hallmark of other parvovirus genera, further distinguishes TuPV and may influence its entry mechanism and pathogenesis [7].

The genetic relationship between TuPV and ChPV is particularly intricate. While they are classified as distinct species within Aveparvovirus galliform1, phylogenetic analyses consistently show them as separate clusters, yet with evidence of frequent genetic exchange [5, 14]. Chacón et al. (2024) demonstrated that selective pressure analysis indicates most coding genes in A. galliform1 are evolving under diversifying (negative) selection, but that recombination and adaptation processes are key drivers of their evolution [5]. The prediction of B-cell and T-cell epitopes revealed several co-localized antigenic peptides between ChPV and TuPV, highlighting immunological cross-reactivity, yet most of these peptides exhibited host-specific variability, suggesting adaptation to the respective avian host [5]. This dynamic is further complicated by the discovery of other parvoviruses in turkeys, such as Chaphamaparvovirus galliform (GaChpV). Aslan et al. (2025) reported the first detection of GaChpV in Turkish turkey flocks, with a prevalence of 6.6% (2/30 flocks), and demonstrated that these strains shared 99-100% nucleotide identity with broiler strains, indicating cross-species circulation [6]. The presence of multiple parvovirus genera (Aveparvovirus and Chaphamaparvovirus) in the same host species adds another layer of complexity to the epidemiology and evolution of enteric disease in turkeys.

Risk Factors, Transmission Dynamics, and Host Susceptibility

The epidemiology of TuPV is shaped by a complex interplay of host, agent, and environmental factors. As a non-enveloped, single-stranded DNA virus, TuPV is highly stable in the environment, facilitating fecal-oral transmission, which is considered the primary route of infection [7, 8]. The detection of TuPV DNA in environmental samples, including litter, drinking water, and swabs from poultry houses, confirms that contaminated fomites and the environment serve as major reservoirs and vehicles for viral spread [8, 12]. The significantly higher prevalence in open-house systems compared to closed houses underscores the role of biosecurity lapses, as open houses are more susceptible to contamination from wildlife, dust, and personnel [8]. The Guangxi surveillance data also revealed that exotic broiler chickens had a higher positive rate (88.10%) for ChPV/TuPV than native chickens (50.00%), suggesting that breed or management intensity may influence susceptibility or exposure [8].

Age is a critical host factor. Multiple studies consistently demonstrate that young birds, particularly those in the first 1-4 weeks of life, are the most susceptible to infection and clinical disease [9, 11, 13]. The Polish study by Domańska-Blicharz et al. (2017) statistically confirmed that young turkeys are particularly vulnerable to infection with rotavirus and astrovirus, and that co-infection with multiple viruses, including parvovirus, is significantly associated with clinical enteritis [9]. This age-dependent susceptibility is likely due to the immaturity of the adaptive immune system in poults and the waning of maternal antibodies. The role of maternal immunity in protecting against TuPV infection remains poorly characterized, but it is a critical area for future research, especially given the lack of vaccination.

The association of TuPV with specific disease syndromes remains a subject of intense investigation. While TuPV is frequently detected in flocks affected by PEC, LTS, and runting-stunting syndrome (RSS), it is also commonly found in healthy birds, complicating the establishment of a direct causal link [9, 11]. The systematic review by Loor-Giler et al. (2025) confirmed that TuPV is one of several viruses (including astrovirus, rotavirus, and reovirus) that are part of the multifactorial etiology of enteric disease in turkeys [13]. The clinical outcome of infection is likely determined by a combination of factors, including the specific viral strain (virulence), the presence of co-infections, the age and immune status of the host, and environmental stressors. The detection of a divergent, potentially recombinant TuPV strain in LTS-affected flocks in Minnesota, but not in non-LTS flocks, suggests that specific genetic variants may be more pathogenic [11]. However, experimental infection studies are urgently needed to fulfill Koch’s postulates and definitively establish the role of specific TuPV genotypes in the pathogenesis of these economically devastating syndromes.

Implications for Surveillance and Control

The epidemiological data on TuPV have profound implications for disease surveillance and control in the global turkey industry. The high prevalence rates, genetic diversity, and evidence of recombination indicate that TuPV is a dynamic and evolving pathogen that requires continuous monitoring. The World Organisation for Animal Health (WOAH) recognizes the economic importance of enteric diseases in poultry, and the data from China, Poland, and the USA underscore the need for TuPV to be included in routine diagnostic panels for enteric disease outbreaks [8, 9, 11]. The use of molecular diagnostic tools, particularly PCR targeting conserved regions of the NS1 gene, has been the mainstay of detection, but the emergence of highly divergent strains (e.g., TuPV-LUB) highlights the risk of false negatives if primers are not regularly updated to reflect circulating genetic diversity [14, 19]. The development and validation of high-throughput quantitative PCR (HT-qPCR) assays, such as those used for microbial source tracking, offer a promising avenue for the simultaneous detection of TuPV alongside other enteric pathogens, enabling a more comprehensive understanding of the virome in affected flocks [24].

Biosecurity remains the cornerstone of control, given the environmental stability of the virus and the lack of commercial vaccines [4, 7]. The data from Guangxi clearly demonstrate that management practices, particularly housing type (open vs. closed) and sanitation of water and litter, are critical modifiable risk factors [8, 12]. All-in/all-out production systems, thorough cleaning and disinfection between flocks, and strict control of personnel and equipment movement are essential to break the cycle of infection. The seasonal pattern of higher prevalence in spring suggests that enhanced biosecurity measures should be implemented during this high-risk period [8]. The detection of TuPV in backyard poultry flocks in Turkey, as reported by Turan et al. (2024), highlights the potential role of these non-commercial operations as reservoirs for the virus, posing a risk to adjacent commercial operations [19]. This finding underscores the need for a "One Health" approach to poultry disease surveillance that integrates both commercial and backyard sectors.

Finally, the absence of a commercial vaccine represents a critical gap in the control of TuPV. The structural characterization of the TuPV capsid by Hsi et al. (2025) provides a crucial foundation for rational vaccine design [4]. The identification of conserved and immunogenic epitopes, as well as the mapping of antigenic variability, could inform the development of recombinant VP2-based subunit vaccines or virus-like particle (VLP) vaccines. However, the high degree of genetic diversity and the potential for immune escape, as suggested by the diversifying selection pressure on capsid genes, pose significant challenges [5]. Any vaccine development effort must be informed by continuous molecular epidemiological surveillance to ensure that vaccine strains are antigenically matched to circulating field strains. The epidemiological data presented here make a compelling case for a coordinated, international effort to monitor TuPV evolution, understand its pathogenesis, and develop effective control strategies to mitigate its impact on global turkey production.

Clinical Manifestations and Pathological Findings in Turkeys

The clinical expression of turkey parvovirus (TuPV) infection spans a spectrum from subclinical enteric carriage to severe, economically devastating enteric disease syndromes that disproportionately afflict juvenile poults during the first several weeks of life. Understanding the full breadth of clinical manifestations and correlative pathological alterations is critically important for accurate field diagnosis, effective flock management, and the design of targeted intervention strategies. The clinical and pathological landscape of TuPV infection is complex, multifactorial, and heavily influenced by host age, immune status, concurrent infections, and viral strain virulence.

Spectrum of Clinical Disease: From Subclinical Carriage to Enteric Disease Syndromes

A critical observation that has emerged from decades of epidemiological surveillance is that TuPV can be detected in both clinically affected and apparently healthy birds. A landmark cross-sectional survey of 207 commercial turkey flocks in Poland between 2008 and 2011, employing molecular detection targeting the non-structural 1 (NS1) gene, demonstrated parvovirus infection in 27.5% of flocks, with detection occurring in both diseased and clinically normal birds [9]. This finding underscores a fundamental principle of TuPV pathobiology: infection does not uniformly equate to disease. The presence of TuPV in healthy birds suggests that host factors, viral load thresholds, and the complex ecological interactions within the intestinal virome collectively determine clinical outcome.

In turkeys that do develop clinical disease, the most frequently reported syndrome is a spectrum of enteric disorders collectively referred to as Poult Enteritis Complex (PEC) or, in older literature, Poult Enteritis and Mortality Syndrome (PEMS). These conditions are characterized by acute or subacute gastroenteritis, diarrhea, stunting, uneven growth within flocks, poor feed conversion, and, in severe cases, elevated mortality [7, 13]. The clinical presentation is often indistinguishable from that caused by other enteric viruses, including astroviruses, rotaviruses, reoviruses, and coronaviruses, which commonly co-circulate in turkey flocks [9, 13]. Compounding this diagnostic challenge, TurPV is frequently detected in mixed infections, with a Polish study documenting dual or triple viral co-infections in approximately 46% of positive flocks [9]. The presence of concurrent viral enteric pathogens amplifies clinical severity, making it difficult to attribute specific clinical signs solely to TuPV.

A particularly severe clinical manifestation strongly associated with TuPV infection in growing turkeys is Runting-Stunting Syndrome (RSS). Affected poults exhibit profound growth retardation, markedly reduced body weight compared to cohort-matched controls, diarrhea often described as watery or mucoid, and pasting of the vent with fecal material [7, 8]. The economic impact of RSS is substantial due to increased culling rates, prolonged time to market weight, and condemnations at processing. Epidemiological surveillance conducted in Guangxi, China, from 2014 to 2019, which employed conserved PCR assays targeting TuPV, found remarkably high viral prevalence in turkey flocks: 83.33% (70/84) of tested turkey samples were positive for TuPV, and the study explicitly linked this detection to clinical RSS in affected poultry populations [8]. This extremely high prevalence rate in Chinese commercial flocks suggests that TuPV is endemic in many intensive production systems and may circulate continuously at high levels even in the absence of overt clinical outbreaks.

Detailed Clinical Signs in PEMS and RSS

The clinical progression of TuPV-associated enteric disease follows a characteristic temporal pattern, though considerable variation exists among flocks. In affected poults, clinical signs typically emerge between one and four weeks of age [9]. Young birds aged 1–4 weeks exhibit the highest prevalence of viral infection, with one Polish study reporting an infection rate of 82.1% in this age cohort, significantly higher than in older birds [9]. This age-dependent susceptibility is consistent with the waning of maternally derived antibodies and the immunological immaturity of the neonatal turkey gut.

The earliest clinical indicators include a sudden onset of diarrhea, with fecal material ranging from watery to mucoid and occasionally containing undigested feed particles. Affected poults rapidly become depressed, huddle together beneath heat sources, and exhibit reduced feed and water intake. Dehydration develops rapidly due to fluid losses from diarrhea, and the vent becomes caked with dried fecal material (vent pasting), which can impede normal defecation and exacerbate the clinical deterioration. Chronically affected birds develop a characteristic “stunted” appearance with poor feathering, pale combs and wattles, and reduced activity levels. The growth differential between affected and unaffected poults can become dramatic within 5–7 days of clinical onset, leading to marked flock size heterogeneity.

In severe PEMS outbreaks, mortality can be significant, particularly when TuPV circulates in conjunction with other enteric pathogens [13]. The mortality is often attributed to a combination of dehydration, electrolyte imbalances, secondary bacterial infections, and malnutrition resulting from malabsorption. Surviving poults rarely achieve full compensatory growth, resulting in permanent stunting and reduced market value. In contrast, some studies, such as the investigation of Light Turkey Syndrome (LTS) in Minnesota, have detected TuPV in flocks with decreased body weight gain but without overt diarrhea or mortality, suggesting that subclinical or low-grade infections still impose significant production penalties [11]. This study tested fecal pools from four LTS flocks and 35 non-LTS flocks, finding that 41 of 80 samples from LTS flocks were parvovirus-positive compared to 20 of 35 from non-LTS flocks, indicating that while TuPV is more prevalent in affected flocks, it is also present in apparently healthy populations [11].

Pathological Findings: Gross and Histopathological Lesions

The pathological lesions associated with TuPV infection are primarily confined to the gastrointestinal tract, although systemic effects secondary to malabsorption and dehydration are common. On gross necropsy, the most consistent finding is intestinal dilatation, with the small intestine, particularly the duodenum and jejunum, appearing flaccid, thin-walled, and distended with gas and watery fluid contents [20]. The intestinal mucosa may appear pale, edematous, and occasionally hemorrhagic in severe cases. The ceca can be distended with frothy brownish fluid, and the bursa of Fabricius may be atrophied in chronically affected birds, reflecting secondary immunosuppression.

More specifically, a study characterizing chicken parvovirus (ChPV) in Brazilian chickens with enteric disease identified a unique pathological presentation in a subset of samples associated with jejunal dilatation (JD), where affected birds exhibited marked dilation of the jejunal loop [20]. While this finding was specifically reported in chickens, the closely related nature of ChPV and TuPV, both members of the Aveparvovirus genus, suggests that analogous pathological changes may occur in turkeys, particularly given the ability of these viruses to undergo recombination and cross-species transmission [14]. Indeed, genetic analysis has revealed recombinant TuPV strains and even ChPV isolates classified within the TuPV genetic group, indicating that the boundary between chicken and turkey parvoviruses is not absolute [14].

Histopathological examination of intestinal tissues from TuPV-affected poults reveals characteristic lesions of viral enteritis. The villi of the small intestine are blunted, fused, and atrophied, with loss of the normal columnar epithelium and reduction in villus height-to-crypt depth ratio [7]. Enterocytes show vacuolation, cytoplasmic swelling, and necrosis, with sloughing of epithelial cells into the intestinal lumen. Crypt hyperplasia is a compensatory response, with elongated and hyperplastic crypts containing increased numbers of mitotic figures. There is a variable infiltration of the lamina propria with lymphocytes, plasma cells, and heterophils, consistent with an active inflammatory response to viral infection. Electron microscopy can detect parvovirus particles (approximately 20–26 nm in diameter) within the nuclei of infected enterocytes, often arranged in paracrystalline arrays, confirming active viral replication in intestinal epithelial cells [7].

Recent structural biology studies utilizing cryo-electron microscopy have provided unprecedented insight into TuPV capsid architecture at a resolution of 2.35 Å, revealing conserved surface depressions at the two-fold symmetry axis and recessed protrusions at the three-fold axis, features that are critical for receptor binding and host cell entry [4]. These structural characterizations have also identified terminal sialic acid as a potential glycan receptor for related aveparvoviruses, suggesting that TuPV may utilize similar sialic acid-containing receptors on the surface of turkey intestinal epithelial cells [4]. The tropism of TuPV for the rapidly dividing cells of the intestinal crypt epithelium is consistent with the known biology of parvoviruses, which require actively dividing cells for productive replication.

The Problem of Co-infections and Subclinical Shedding

A recurring theme in TuPV research is the high frequency of co-infections with other enteric viruses. The Polish survey documented that among 137 virus-positive flocks, 54 were co-infected with two or three different enteric viruses, and the statistical analysis indicated a significant association between multiple viral infections and clinical disease [9]. This finding has profound implications for understanding TuPV pathogenicity; it suggests that TuPV alone may be insufficient to cause severe clinical disease in many cases, but that it acts synergistically with other viral agents to produce the full PEMS or RSS phenotype. The most common co-infecting agents identified alongside TuPV include turkey astrovirus, rotavirus, and coronavirus [9, 13]. The detection of TuPV, astrovirus, and rotavirus together in young poults with diarrhea and stunting is a frequent diagnostic finding in commercial turkey production worldwide.

Furthermore, TuPV can be shed in the feces of clinically normal birds, contributing to environmental contamination and perpetuating the infection cycle within and between flocks. Environmental surveillance in Chinese poultry farms detected TuPV in 47.05% of environmental samples, including litter, drinking water, and swabs from poultry houses, with higher prevalence in open housing systems compared to closed houses [8, 12]. This environmental persistence, combined with the virus’s ability to survive in organic material and resist common disinfectants, makes eradication from contaminated facilities extremely challenging. The seasonal pattern of higher detection rates in spring further complicates control efforts, as this period coincides with peak poult placement in many production systems [8, 12].

Recent investigations have also identified novel parvoviruses in turkeys, including Chaphamaparvovirus galliform (GaChpV), which was detected in 6.6% of turkey flocks in Türkiye, demonstrating that the parvoviral landscape in turkeys extends beyond the classic TuPV [6]. Notably, this study found no statistically significant association between GaChpV detection and enteritis cases, further supporting the concept that parvovirus detection alone, even with novel agents, does not confirm etiological involvement in clinical disease [6]. The detection of multiple parvovirus species in both diarrheic and healthy turkeys highlights the critical importance of well-designed experimental infection studies using specific-pathogen-free poults to definitively establish the pathogenic role of each viral agent in the complex enteric disease syndromes that plague the global turkey industry.

Diagnostic Approaches for TuPV Detection and Surveillance

The accurate detection and surveillance of turkey parvovirus (TuPV) necessitates a multi-tiered diagnostic arsenal, evolving from traditional molecular techniques to advanced high-throughput platforms. Given the virus’s association with enteric disease syndromes such as Poult Enteritis Complex (PEC) and Light Turkey Syndrome (LTS) [11, 13], and its documented presence in both clinically affected and apparently healthy flocks [9], diagnostic strategies must balance sensitivity, specificity, and epidemiological scalability. The genomic architecture of TuPV, a member of the Aveparvovirus genus within the Parvoviridae family, presents unique challenges and opportunities for detection. Unlike many mammalian parvoviruses, the VP1-unique region of avian parvoviruses lacks the phospholipase A2 (PLA2) motif, a feature that has implications for both capsid function and the design of serological assays [7]. The single-stranded DNA genome, encoding non-structural protein 1 (NS1), nuclear phosphoprotein (NP), and the overlapping structural proteins VP1 and VP2 [7, 10], provides multiple conserved and variable genetic targets for amplification-based diagnostics.

Conventional and Nested Polymerase Chain Reaction (PCR) for TuPV

The cornerstone of TuPV detection, particularly in resource-limited settings or large-scale surveillance, remains conventional PCR targeting highly conserved genomic regions. The NS1 gene, owing to its essential replicative functions and relative conservation across Aveparvovirus species, has been the most frequently exploited target. Early foundational work in Polish turkey flocks between 2008 and 2011 utilized PCR primers directed against the NS1 gene, reporting a TuPV prevalence of 29.4% in 197 commercial turkey flocks and identifying a novel distinct subgroup (TuPV-LUB) with nucleotide identities as low as 50.6-64.5% to prototype strains [14]. This work underscored the critical need for primer sets capable of detecting significant genetic divergence. Similarly, investigations into Minnesota turkeys used NS1-targeted PCR to detect TuPV in 51.25% of fecal pools from flocks with LTS and 57.14% from non-LTS flocks, revealing circulation even within apparently healthy populations [11]. Crucially, this study also identified a divergent strain with only 90% nucleotide identity to known TuPV, clustering with chicken-like parvoviruses, suggesting that PCR-based surveillance must be constantly validated against emerging recombinants [11]. The detection of TuPV in Guangxi, China, between 2014 and 2019, relied on conserved PCR assays that interrogated a staggering 3,470 samples, revealing a 51.73% prevalence across commercial fowl and demonstrating the feasibility of PCR for massive epidemiological mapping [8, 12]. The high prevalence in environmental samples, including 47.05% positivity in poultry house environments (litter, drinking water, swabs), confirms that PCR-based detection can be effectively applied to non-invasive environmental surveillance, a critical tool for understanding farm-level contamination and transmission dynamics [8, 12].

Advances in sensitivity have been achieved through nested PCR approaches. A comparative study of primer sets for detecting chicken parvovirus (ChPV) in backyard Turkish poultry flocks explicitly demonstrated that a nested PCR approach significantly outperformed conventional PCR, yielding positivity percentages of up to 44.6% compared to as low as 7.9% with other single-round methods [19]. Although this study focused on ChPV, the phylogenetic proximity and genomic homology between ChPV and TuPV [5] make these findings directly applicable to TuPV diagnostics. The authors “Therefore, the nested PCR approach developed in this study might be an alternative to other conventional PCR primers owing to its increased sensitivity” [19]. This enhanced sensitivity is particularly vital when screening samples from adult birds or environmental matrices, where viral loads may be substantially lower than in acutely infected poults. Furthermore, the investigation of Chaphamaparvovirus galliform (GaChpV) in Turkish broiler and turkey flocks employed nested PCR with specific primer sets, successfully detecting GaChpV in 6.6% of turkey flocks (2 out of 30), demonstrating that nested protocols are indispensable for uncovering low-prevalence or co-infecting parvoviruses [6]. It is important to note that while TuPV and GaChpV are distinct viral species, their co-circulation in turkeys [6] mandates diagnostic panels that can differentiate between these agents. The non-structural protein gene targets used in many PCR assays may cross-react if not carefully designed, necessitating sequencing or restriction fragment length polymorphism (RFLP) analysis for definitive speciation.

Quantitative Real-Time PCR for TuPV

For precise viral load quantification and high-throughput surveillance, quantitative real-time PCR (qPCR) has been adapted from other parvovirus diagnostic paradigms. The application of real-time PCR for parvovirus B19 detection in human blood, reaching a sensitivity of 101 copies/mL [27], and for goose parvovirus (GPV) detection in Turkey [25], demonstrates the proven utility of this platform. In the context of TuPV, the principles of real-time PCR allow for the simultaneous amplification and quantification of viral DNA, typically targeting the NS1 or VP2 genes. The superiority of real-time PCR over conventional PCR for epidemiological sensitivity was exemplified in a study of canine parvovirus (CPV-2) in the Black Sea region of Turkey, where real-time PCR detected viral nucleic acid in 24 out of 45 clinically suspected dogs, outperforming other diagnostic modalities [28]. For TuPV, the validation of high-throughput qPCR (HT-qPCR) platforms for environmental water testing has incorporated a chicken/turkey parvovirus-specific microbial source tracking marker, demonstrating its utility in detecting fecal contamination originating from poultry operations [24]. This work, which compared HT-qPCR to standard qPCR, found “results of HT-qPCR were in agreement with the standard qPCR,” validating the use of this platform for parvovirus surveillance in complex environmental matrices [24]. The ability of qPCR to provide both qualitative presence/absence data and quantitative viral copy numbers is essential for establishing dose-response relationships in experimental infection models and for monitoring the efficacy of biosecurity interventions. The development of TuPV-specific qPCR assays must, however, account for the genetic heterogeneity observed in the NS1 and VP2 genes. Recombination events can lead to chimeric genomes that may escape detection if the primers sit within recombination breakpoints [1, 14]. As such, validated qPCR assays for TuPV should target a highly conserved region, often within the NS1 gene, and undergo periodic re-validation against newly sequenced field strains.

Serological Approaches and Immunoassays

Serological detection of antibodies against TuPV provides a historical record of exposure within a flock, which is invaluable for understanding transmission patterns and optimizing vaccination strategies, should a vaccine become available. The primary serological tool developed for poultry parvoviruses is the enzyme-linked immunosorbent assay (ELISA) utilizing recombinant VP2 or VP1 capsid proteins [7]. This approach leverages the immunodominant nature of the viral capsid, which is the primary target of the host humoral immune response. The structural characterization of the TuPV capsid via cryo-electron microscopy at a resolution of 2.35 Å [4] provides a detailed atomic-level roadmap for designing antigenic bait for serological assays. The study by Hsi et al. explicitly notes that “The structural characterization of its capsid may contribute toward the development of a treatment to control the spread of infection” [4]. Furthermore, in silico prediction of B-cell and T-cell epitopes on ChPV and TuPV capsids has revealed “several co-localized antigenic peptides from ChPV and TuPV, especially for T-cell epitopes,” indicating that cross-reactive serological assays are both a possibility and a risk [5]. An ELISA based on recombinant VP2 from a specific TuPV strain may fail to detect antibodies against antigenically divergent strains, particularly those with mutations in predicted B-cell epitope regions [3, 5]. Therefore, a multi-strain antigen cocktail may be necessary for a broadly reactive serological surveillance tool.

The application of serological techniques in turkey flocks has been limited compared to molecular detection, largely due to the absence of a commercial vaccine and the difficulty in interpreting serological data in the context of a ubiquitous, often subclinical infection. However, the principles established for other parvoviruses are instructive. For example, the investigation into canine parvovirus in Cuba utilized serology to establish risk factors. For TuPV, serological surveillance can identify seropositive breeder flocks, which may passively transfer maternal antibodies to poults, potentially confounding detection efforts in young birds. The development of a robust, validated ELISA would also permit the epidemiological differentiation of recent infection (IgM) versus past exposure (IgG), although the utility of isotype-specific reagents in poultry requires further investigation. The widespread use of ELISAs for pathogen surveillance in other poultry viruses suggests a clear pathway for TuPV serodiagnosis, but it remains a significant gap in the current diagnostic toolkit.

Advanced Genomic and Metagenomic Approaches

The most profound insights into TuPV genetic diversity, evolution, and ecology have emerged from whole-genome sequencing and metagenomic analysis. The application of next-generation sequencing (NGS) has transformed our ability to detect TuPV without a priori sequence knowledge. Viral metagenomics, employing sequence-independent amplification techniques, has been championed as a powerful tool for “rapid and simultaneous detection of the parvovirus from affected and healthy birds” [7]. This approach was instrumental in the initial discovery of chaphamaparvoviruses in avian species, including turkeys, and remains the gold standard for characterizing the complete enteric virome of poultry flocks [5, 6]. For instance, a metagenomic investigation of broiler flocks affected with runting-stunting syndrome (RSS) successfully assembled prevalent genomes identified as ChPV, consistently clustering separately from TuPV, while also detecting signatures of genomic recombination in the USP-574-A strain [5]. This demonstrates that NGS is not merely a confirmation tool but a discovery engine for detecting recombinant and novel viral variants.

Whole-genome characterization of TuPV field strains has been performed using traditional PCR coupled with Sanger sequencing, as well as NGS. The complete genome of the GX-Tu-PV-1 strain from Guangxi, China, was obtained via traditional PCR, providing a reference genome with 81.3% to 99.3% similarity to other TuPVs [2]. Larger-scale studies, such as the characterization of 35 ChPV/TuPV field strains from Guangxi, utilized both PCR and Sanger sequencing to obtain whole genomes, revealing 15 recombinants using RDP5.0 software [1]. The application of NGS for other parvoviruses, such as the whole-genome sequencing of CPV-2 isolates from dogs in Turkey using NGS [21, 22], establishes the technical capacity for similar high-throughput sequencing of TuPV. The phylogenetic analyses derived from these full-genome data are crucial for molecular epidemiological tracking, demonstrating that “Guangxi ChPV/TuPV strains did not cluster according to their geographic origin” and that novel genetic groups are emerging [1]. These data are the bedrock for designing targeted diagnostics and for monitoring the efficacy of any future control measures.

Integrated Surveillance Strategies and Diagnostic Algorithms

Given the clinical presentation of TuPV infection, which overlaps with astrovirus, rotavirus, reovirus, and coronavirus infections [9, 13], a diagnostic algorithm for enteric disease in turkeys must employ a syndromic, multi-pathogen approach. The World Organization for Animal Health (WOAH) and Food and Agriculture Organization (FAO) advocate for integrated surveillance of economically critical poultry pathogens. For TuPV, a tiered diagnostic strategy is recommended. Primary screening of flock-level fecal pools or environmental samples (litter, boot swabs) should utilize a sensitive real-time or nested PCR targeting the NS1 or VP2 genes. Positive samples should then undergo genotyping via partial or full VP2/VP1 sequencing to identify circulating strains and detect potential recombination events. Serological profiling using a recombinant VP2 ELISA can be deployed for longitudinal studies within flocks or regions to determine force of infection. In cases of diagnostic uncertainty or outbreaks of severe enteric disease, viral metagenomics provides a comprehensive view of the entero-pathogenic community, capable of detecting TuPV, GaChpV, astroviruses, and other co-infecting agents without bias [5, 6].

The high prevalence of TuPV in both diseased and healthy birds [9, 11] complicates the interpretation of a positive PCR result. Therefore, surveillance efforts must incorporate quantitative data (viral load via qPCR) and correlate it with clinical signs and histopathological lesions, such as villous atrophy and crypt hyperplasia, to establish causality. Sampling strategies must also account for age-related susceptibility, as “young turkeys aged 1-4 weeks old had the highest (82.1%) prevalence of viral infection” [9] and that “spring” seasons show higher detection rates in China [8, 12]. Longitudinal surveillance across production cycles is essential to distinguish between transient low-level shedding and active epizootic transmission. The ongoing genetic drift and recombination in TuPV [1, 5, 14] mandates that all diagnostic primers and probes are periodically reassessed against the most recent sequence data available in public databases such as GenBank. The recent demonstration of a diverse array of genetic groups for ChPV in Brazil, using VP1 gene analysis, underscores the global nature of parvoviral diversity [20]. Adopting a One Health perspective, integrated surveillance networks that connect veterinary diagnostic laboratories, poultry industry stakeholders, and wildlife monitoring programs could provide early warning of emerging TuPV variants with altered pathogenicity or host range, as interspecies transmission between chickens and turkeys has been well-documented [1, 8].

Evolutionary Dynamics, Recombination, and Emerging Variants

The evolutionary trajectory of Turkey Parvovirus (TuPV) is characterized by a complex interplay of mutation, recombination, and selective pressures that have shaped its emergence as a globally distributed pathogen of commercial and backyard poultry. As a member of the genus Aveparvovirus within the subfamily Parvovirinae, TuPV shares a fundamental genomic architecture with other avian parvoviruses, yet its evolutionary dynamics are distinct, marked by high rates of genetic recombination and the continuous emergence of novel lineages that challenge traditional phylogenetic classification [7, 13]. Understanding these dynamics is not merely an academic exercise; it is essential for predicting future outbreaks, assessing vaccine cross-protection, and implementing effective biosecurity measures.

3.1 Genetic Architecture and Taxonomic Considerations

The TuPV genome is a linear, single-stranded DNA molecule of approximately 5.0–5.5 kilobases, containing three open reading frames (ORFs). The first two ORFs encode the non-structural protein (NS1/NS2) and the nuclear phosphoprotein (NP), while the third ORF encodes the structural capsid proteins VP1 and VP2 [7]. Notably, and in contrast to many mammalian parvoviruses, the VP1-unique region of TuPV and other aveparvoviruses lacks the canonical phospholipase A2 (PLA2) sequence motif, a feature that has implications for host range and entry mechanisms [7]. The capsid, determined at a near-atomic resolution of 2.35 Å for TuPV through cryo-electron microscopy, exhibits a T=1 icosahedral symmetry with conserved features such as a channel at the five-fold symmetry axis and surface depressions at the two-fold axis. However, major structural differences are observed at the three-fold axes, where TuPV displays recessed protrusions distinct from those seen in mammalian parvoviruses [4]. This structural characterization, the first for any aveparvovirus, provides a critical framework for understanding how mutations in the capsid genes, particularly in VP2, translate into antigenic variation and potential immune evasion.

Phylogenetic analyses consistently demonstrate a clear division between TuPV and Chicken Parvovirus (ChPV), forming two distinct clusters within the Aveparvovirus galliform1 species [5, 11]. However, this division is not absolute. Recombination events have blurred the boundaries between these two viral populations, leading to the emergence of chimeric strains that complicate taxonomic assignment and challenge our understanding of host specificity [5, 14]. The recent large-scale surveillance in Guangxi, China, identified six distinct phylogenetic groups among ChPV/TuPV field strains, including three novel groups that had not been previously described [1]. This indicates that the genetic diversity of these viruses is far from saturated and that reservoirs of previously unrecognized lineages persist in poultry populations.

3.2 Recombination as a Primary Driver of Genetic Diversification

Recombination is arguably the most potent evolutionary force shaping TuPV populations. Multiple independent studies have documented high rates of recombination across geographically distinct regions. In the Guangxi province of China, whole-genome analysis of 35 field strains using RDP 5.0 identified 15 recombinants (42.9% of isolates), events that were subsequently confirmed by Simplot 3.5.1 analysis [1]. Similarly, in a study of ChPV from central and eastern China, recombination analysis suggested four recombinant strains among 18 sequenced isolates, with parental strains originating from both China and the United States, highlighting the transcontinental movement of viral genetic material [3].

The biological consequences of recombination are profound. The Polish study conducted between 2008 and 2011 provided early evidence of a ChPV isolate that clearly clustered within the TuPV group based on partial NS1 gene analysis, strongly suggesting an inter-species recombination event between chicken and turkey parvoviruses [14]. This finding has since been corroborated by metagenomic characterization of strains associated with runting-stunting syndrome (RSS), where the USP-574-A strain showed clear signs of genomic recombination [5]. The presence of such recombinant strains has significant implications: they can combine the replicative efficiency of one parental type with the antigenic properties of another, potentially leading to viruses that are both highly fit and capable of evading pre-existing immunity in vaccinated flocks.

The recombination events are not limited to the structural genes. The NS1 gene, which is essential for viral replication, has also been shown to participate in recombination. In one of the most striking examples, a divergent TuPV strain detected in Minnesota turkey flocks exhibiting Light Turkey Syndrome (LTS) shared only 90% nucleotide identity with other TuPV strains in the partial NS1 gene and clustered with chicken-like parvoviruses, providing further evidence of interspecies recombination in the field [11]. The structural characterization of the TuPV capsid [4] now allows researchers to map these recombination boundaries onto the three-dimensional structure, offering mechanistic insights into how chimeric capsids retain functionality.

3.3 Mutation, Selective Pressure, and Antigenic Variation

While recombination generates large-scale genomic rearrangements, point mutations provide the substrate for more subtle, continuous antigenic drift. A comprehensive analysis of selective pressure within the Aveparvovirus galliform1 species revealed that most coding genes are evolving under purifying (negative) selection, suggesting strong functional constraints [5]. However, specific regions within the capsid proteins, particularly the VP2 hypervariable regions, are subject to diversifying selection, indicative of ongoing adaptation to host immune responses.

The VP2 gene is the primary target of neutralizing antibodies, and its evolution is therefore critical for vaccine development. Amino acid sequence alignments between ChPV and TuPV strains from Guangxi and global reference strains revealed identities ranging from 87.8% to 100% [1]. Within this variation, specific hypervariable regions have been identified in the VP1 (residues 250–267 and 611–667) and VP2 proteins, as well as in the NS1 protein (regions 319–334 and 637–647) [3]. Importantly, 22 amino acid substitutions were identified within predicted B-cell epitope regions of the capsid proteins of emerging Chinese strains [3], a finding that directly informs the risk of immune escape in vaccinated populations.

The immunological significance of these mutations is underscored by epitope prediction analyses comparing ChPV and TuPV. While several co-localized antigenic peptides, particularly T-cell epitopes, are shared between the two viruses, most of these peptides exhibit host-specific variability, obeying an adaptive scenario driven by the differing immune pressures exerted by chickens versus turkeys [5]. This host-specific adaptation implies that a vaccine developed against a chicken-derived strain may confer suboptimal protection in turkeys, and vice versa.

3.4 Emergence of Novel Variants and Implications for Classification

The continuous emergence of novel variants necessitates a flexible classification framework. A recently proposed genotyping system for ChPV, based on the p-distance frequency distribution of VP2 amino acid sequences, classifies strains into two major genotypes, CKPV-1 (with subtypes CKPV-1a and CKPV-1b) and CKPV-2 (with subtypes CKPV-2a, CKPV-2b, and CKPV-2c) [3]. While this system was developed for chicken isolates, the phylogenetic intermingling of TuPV and ChPV strains in many analyses suggests that a unified genotyping framework for galliform aveparvoviruses may be warranted.

The detection of TuPV strains in novel geographic regions continues to expand our understanding of viral diversity. The first detection of Chaphamaparvovirus galliform (GaChpV) in turkey flocks in Turkey revealed that Turkish GaChpV strains exhibited 99–100% nucleotide identity among themselves but only 73–98% similarity to European, Chinese, and Brazilian strains, indicating substantial local diversification [6]. Additionally, the genetic characterization of the GX-Tu-PV-1 strain from Guangxi, which showed 81.3% to 99.3% similarity to other TuPVs and 79.8% to 92.1% similarity to ChPVs [2], underscores the fluid nature of species boundaries within this group.

3.5 Epidemiological Implications and Future Trajectories

The evolutionary dynamics of TuPV have direct and tangible consequences for disease control. The absence of a commercial vaccine against TuPV [7] means that control relies entirely on biosecurity and management practices. However, the high prevalence of TuPV in turkey flocks, reported at 27.5% in Poland [9], 83.33% in Guangxi turkey farms [8, 12], and with evidence of circulation in both LTS and non-LTS flocks in Minnesota [11], suggests that the virus is endemic in many turkey-producing regions worldwide. The detection of TuPV in environmental samples (litter, drinking water, and swabs from poultry houses) at rates of 47.05% [8] indicates that contaminated fomites serve as a persistent source of infection, facilitating the maintenance of viral populations and increasing opportunities for co-infection and recombination.

The relationship between TuPV and enteric disease syndromes remains complex. While TuPV has been associated with poultry enteritis and mortality syndrome (PEMS) in turkeys and runting-stunting syndrome (RSS) in chickens, it is frequently detected in healthy birds as well [7, 11, 13]. The systematic review by Loor-Giler et al. (2025) emphasized that enteric viruses often act in co-infection, increasing clinical severity [13]. This co-infection dynamic is highly relevant to evolutionary dynamics because it provides the necessary condition for recombination, simultaneous infection of a single cell by two distinct viruses. Experimental studies are urgently needed to determine whether recombinant TuPV strains exhibit altered pathogenicity or tissue tropism.

Future surveillance efforts should prioritize whole-genome sequencing over partial gene analysis to capture the full extent of recombination events. The evolution of TuPV is not a linear process of gradual divergence but rather a network of genetic exchange, shaped by the ecology of intensive poultry production, global trade, and the immunological landscape of vaccinated and unvaccinated flocks. The emergence of novel genotypes, the evidence of inter-species recombination between chicken and turkey parvoviruses, and the detection of TuPV in wild bird populations [13] highlight the potential for this virus to continue evolving in unpredictable ways, with implications for food security and the economic sustainability of the global turkey industry as recognized by the World Organisation for Animal Health (WOAH).

References

[1] Zhang Y, Feng B, Xie Z, Zhang M, Fan Q, Deng X, et al.. Molecular characterization of emerging chicken and turkey parvovirus variants and novel strains in Guangxi, China. Scientific Reports. 2023. DOI: https://doi.org/10.1038/s41598-023-40349-5

[2] Zhang Y, Xie Z, Deng X, Xie Z, Xie L, Zhang M, et al.. Molecular Characterization of Parvovirus Strain GX-Tu-PV-1, Isolated from a Guangxi Turkey. Microbiology Resource Announcements. 2019. DOI: https://doi.org/10.1128/MRA.00152-19

[3] Xu X, Zhang Z, Wang Y, Li D, Yao L, Ji J, et al.. Novel genotyping and genetic heterogeneity of chicken parvovirus in central and Eastern China. Poultry Science. 2025. DOI: https://doi.org/10.1016/j.psj.2025.105997

[4] Hsi J, Mietzsch M, Patney M, Chen S, Sawh-Gopal A, Chipman P, et al.. Birds of a feather flock together: structural characterization of red-crowned crane and turkey aveparvoviruses. Journal of Virology. 2025. DOI: https://doi.org/10.1128/jvi.00110-25

[5] Chacón RD, Sánchez-Llatas CJ, Costa ACd, Ichillumpa SV, Cea-Callejo P, Marín-Sánchez O, et al.. Molecular and Evolutionary Characteristics of Chicken Parvovirus (ChPV) Genomes Detected in Chickens with Runting–Stunting Syndrome. Viruses. 2024. DOI: https://doi.org/10.3390/v16091389

[6] Aslan AN, Abayli H, Tonbak S, Ongor H, Unal A, Akan M, et al.. First detection and molecular characterization of Chaphamaparvovirus galliform in broiler and turkey flocks in Türkiye. BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-025-04612-3

[7] Kapgate S, Kumanan K, Vijayarani K, Barbuddhe S. Avian parvovirus: classification, phylogeny, pathogenesis and diagnosis. Avian Pathology. 2018. DOI: https://doi.org/10.1080/03079457.2018.1517938

[8] Zhang Y, Feng B, Xie Z, Deng X, Zhang M, Xie Z, et al.. Epidemiological Surveillance of Parvoviruses in Commercial Chicken and Turkey Farms in Guangxi, Southern China, During 2014–2019. Frontiers in Veterinary Science. 2020. DOI: https://doi.org/10.3389/fvets.2020.561371

[9] Domańska-Blicharz K, Bocian Ł, Lisowska A, Jacukowicz A, Pikuła A, Minta Z. Cross-sectional survey of selected enteric viruses in Polish turkey flocks between 2008 and 2011. BMC Veterinary Research. 2017. DOI: https://doi.org/10.1186/s12917-017-1013-8

[10] Akkutay-Yoldar Z, B. T. Phylogenetic analysis of canine parvoviruses from Turkey. Medycyna Weterynaryjna. 2020. DOI: https://doi.org/10.21521/mw.6334

[11] Sharafeldin T, Singh A, Abdel-Glil MY, Mor S, Porter R, Goyal S. Prevalence of parvovirus in Minnesota turkeys. Poultry Science. 2017. DOI: https://doi.org/10.3382/ps/pew283

[12] Zhang Y, Bin F, Xie Z, Deng X, Zhang M, Xie Z, et al.. Epidemiological Surveillance of Parvoviruses in Commercial Chicken and Turkey Farms in Guangxi, Southern China, During 2014-2019.. Frontiers in Veterinary Science. 2020. DOI: https://doi.org/10.3389/FVETS.2020.561371

[13] Loor-Giler A, Galdo-Novo S, Nuñez LFN. Enteric Viruses in Turkeys: A Systematic Review and Comparative Data Analysis. Viruses. 2025. DOI: https://doi.org/10.3390/v17081037

[14] Domańska-Blicharz K, Jacukowicz A, Lisowska A, Minta Z. Genetic characterization of parvoviruses circulating in turkey and chicken flocks in Poland. Archives of Virology. 2012. DOI: https://doi.org/10.1007/s00705-012-1446-0

[15] Yang S, Liu Z, Wang Y, Li W, Fu X, Lin Y, et al.. A novel rodent Chapparvovirus in feces of wild rats. Virology Journal. 2016. DOI: https://doi.org/10.1186/s12985-016-0589-0

[16] Phan T, Vo NP, Boros Á, Pankovics P, Reuter G, Li O, et al.. The Viruses of Wild Pigeon Droppings. PLoS ONE. 2013. DOI: https://doi.org/10.1371/journal.pone.0072787

[17] Adebiyi A, McIlwaine K, Oluwayelu D, Smyth V. Detection and characterization of chicken astrovirus associated with hatchery disease in commercial day-old turkeys in southwestern Nigeria. Archives of Virology. 2021. DOI: https://doi.org/10.1007/s00705-021-05034-w

[18] Adebiyi A, Tregaskis PL, Oluwayelu D, Smyth V. Investigation of Enteric Viruses Associated With Runting and Stunting in Day-Old Chicks and Older Broilers in Southwest Nigeria. Frontiers in Veterinary Science. 2019. DOI: https://doi.org/10.3389/fvets.2019.00239

[19] Turan T, Kalin R, Işıdan H, Atasoy M. Investigation of the Presence of Chicken Parvovirus in Turkish Backyard Poultry Flocks: A Comparative Analysis of PCR Primer Sets. Journal of the Hellenic Veterinary Medical Society. 2024. DOI: https://doi.org/10.12681/jhvms.35373

[20] Nuñez LFN, Santander-Parra S, Astolfi-Ferreira C, Loor-Giler A, Ferreira AP. Molecular Characterization of the Chicken Parvovirus Based on VP1 Gene Circulating in Brazilian Chicken Flocks. Microorganisms. 2024. DOI: https://doi.org/10.3390/microorganisms12061065

[21] Temizkan M, Temizkan SS. Canine Parvovirus in Turkey: First Whole-Genome Sequences, Strain Distribution, and Prevalence. Viruses. 2023. DOI: https://doi.org/10.3390/v15040957

[22] Abayli H, Aslan O, Tumer K, Can-Sahna K, Tonbak S. Predominance and first complete genomic characterization of canine parvovirus 2b in Turkey. Archives of Virology. 2022. DOI: https://doi.org/10.1007/s00705-022-05509-4

[23] Polat P, Şahan A, Aksoy G, Timurkan M, Dinçer E. Molecular and restriction fragment length polymorphism analysis of canine parvovirus 2 (CPV-2) in dogs in southeast Anatolia, Turkey. Onderstepoort Journal of Veterinary Research. 2019. DOI: https://doi.org/10.4102/ojvr.v86i1.1734

[24] Raya S, Malla B, Thakali O, Angga M, Segawa T, Sherchand J, et al.. Validation and application of high-throughput quantitative PCR for the simultaneous detection of microbial source tracking markers in environmental water.. Science of the Total Environment. 2024. DOI: https://doi.org/10.1016/j.scitotenv.2024.173604

[25] Bulut O, Dik I, Aslım HP, Avci C, Palancı HS, Akbaba S, et al.. Molecular characterization of goose parvovirus in geese of Turkey. Pesquisa Veterinária Brasileira. 2021. DOI: https://doi.org/10.1590/1678-5150-pvb-6903

[26] Işıdan H, Turan T, Atasoy M, Coşkun A. Molecular analysis of goose parvovirus field strains from the Derzsy’s disease outbreak revealed the local European-associated variants. . 2021. DOI: https://doi.org/10.21203/RS.3.RS-260589/V1

[27] Guclu AU, Yılmaz S, Baysallar M, Avci IY. Prevalence and Quantity of Parvovirus B19 DNA Among Blood Donors from a Regional Blood Center in Turkey.. Transfusion and Apheresis Science. 2020. DOI: https://doi.org/10.1016/j.transci.2020.102775

[28] Kuruçay H, Gumusova S. Virological investigation on the presence of CPV-2 in the Middle Black Sea Region of Turkey. Polish journal of veterinary sciences. 2026. DOI: https://doi.org/10.24425/pjvs.2026.158496